Sandbox:TarekNafee: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 4: Line 4:
! colspan="1" rowspan="2"| Disease
! colspan="1" rowspan="2"| Disease
! colspan="3" rowspan="1"| Diagnosis
! colspan="3" rowspan="1"| Diagnosis
! colspan="1" rowspan="2"| Vertical Transmission
! colspan="2" rowspan="1"| Mother to Child Transmission
! colspan="1" rowspan="2"| Most Serious Complications
! colspan="1" rowspan="2"| Most Serious Complications
|-
|-
! colspan="1" rowspan="1"| Laboratory studies || Clinical Diagnosis || Procedure
! colspan="1" rowspan="1"| Laboratory studies || Clinical Diagnosis || Procedure || Vertical Transmission || Trans-vaginal transmission
|-
|-
! colspan="1" rowspan="9"| Primarily sexually transmitted  
! colspan="1" rowspan="9"| Primarily sexually transmitted  

Revision as of 21:53, 18 October 2016

Transmission Clinical Presentation Disease Diagnosis Mother to Child Transmission Most Serious Complications
Laboratory studies Clinical Diagnosis Procedure Vertical Transmission Trans-vaginal transmission
Primarily sexually transmitted Genital ulceration/Dermatitis Disease X X X X X Death
Disease Y X X X X Death
Disease Z X X X X Death
Generalized Symptoms Disease X X X X X Death
Disease Y X X X X Death
Disease Z X X X X Death
PID Disease X X X X X Death
Disease Y X X X X Death
Disease Z X X X X Death
Secondarily sexually transmitted Genital ulceration/Dermatitis Disease X X X X X Death
Disease Y X X X X Death
Disease Z X X X X Death
Generalized Symptoms Disease X X X X X Death
Disease Y X X X X Death
Disease Z X X X X Death
PID Disease X X X X X Death
Disease Y X X X X Death
Disease Z X X X X Death